The Stockholm stock exchange climbed for a third consecutive day on Wednesday, bolstered by positive momentum on global markets.
In the news flow, defense company Saab secured a submarine order from Poland. Verisure and Elekta delivered the day's most significant quarterly reports, with Elekta receiving a particularly warm reception, while Surgical Science plummeted following a terminated letter of intent.
At the close, the OMXS30 index was up 0.77 percent at 2,779.44. Shares worth approximately SEK 18.7 billion changed hands on the Stockholm exchange.
Among the major industrial sectors, raw materials outperformed with a gain of 1.2 percent. In contrast, telecommunications and technology lagged, rising just 0.3 percent.
Within the leading OMXS30 stocks, Boliden surged 4.0 percent while Saab B climbed 2.4 percent. Skanska B fared worst, falling 1.1 percent, while SCA B slipped 0.5 percent.
Poland has chosen to order three new A26 submarines from defense giant Saab. The contract has yet to be signed, but the deal is expected to be worth several billion dollars.
Alarm company Verisure reported higher revenue and increased adjusted operating profit in the third quarter compared to the same period last year. This marks its first report since its listing on the Stockholm exchange on October 8. Annual recurring revenue grew by 10.2 percent, and the number of new installations increased by 5.2 percent. The company expects annual recurring revenue to rise by over 12 percent for the full year, with an adjusted operating profit of EUR940-950 million. The stock initially rose and remained in positive territory for much of the day but closed down 0.3 percent.
Medtech company Elekta's second-quarter operating profit came in above analysts' expectations, while revenue and order intake were in line with consensus. The company maintained its previous full-year forecast for 2025/26. Elekta also announced a cost-saving program aiming to reduce expenses by at least SEK 500 million annually, which will result in 450 job cuts. The stock soared 23 percent.
Industrial group Atlas Copco held a capital markets day, confirming its latest market outlook from the October 23 interim report. The company expects customer activity to remain at current levels. The A share slipped 0.5 percent.
Surgical simulator company Surgical Science warned of a negative impact on its license revenue of SEK 60-90 million next year compared to 2025. The background is that customer Intuitive opted to terminate the letter of intent with Surgical Science, which would have integrated the company's simulation software into all da Vinci robotic systems. The news sent the stock tumbling 60 percent.
Gaming company Embracer reached an agreement to divest Arc Games and Cryptic Studios to Project Golden. The expected net proceeds from the deal are $30 million, equivalent to SEK 287 million. The stock climbed 5.8 percent.
Real estate company Castellum's board adopted a new strategy, targeting an annual return on equity of at least 10 percent over an economic cycle. Simultaneously, its dividend policy was replaced by a capital distribution policy, mandating that at least 25 percent of management profits be returned to shareholders, either as cash dividends or share buybacks. The stock rose 1.1 percent.
Greentech company Saltx Technology fell 12 percent after announcing a rights issue of SEK 100 million.
Mining company Boliden's rally was attributed to Deutsche Bank upgrading its recommendation to "buy" from "hold."
Automotive safety company Autoliv gained 1.8 percent after JP Morgan raised its recommendation to "overweight" from "neutral."
Pharmaceutical development company Egetis Therapeutics dropped 14 percent after Pareto Securities issued a sell recommendation.
